Results · Apr-Jun 2026 · filed 10 Aug 2026
Indo Borax & Chemicals Q1 FY27 results
BlockbusterBlockbuster: sales up 20% or more & profit up 30% or more on the same quarter last year, with a wider operating margin.
Sales grew 31% to ₹70.4 crore from ₹53.6 crore in Apr-Jun 2025.
Operating profit grew 62% to ₹19.8 crore, an operating margin of 28.1% (up 5.3 points from a year ago).
Net profit grew 59% to ₹16.3 crore from ₹10.2 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +12%, net profit +12%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 70.4 | 53.6 | +31% |
| Operating profit (EBITDA) | 19.8 | 12.2 | +62% |
| Operating margin | 28.1% | 22.8% | +5.3 pts |
| Net profit | 16.3 | 10.2 | +59% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The earnings call
Apr–Jun 2026 saw operating revenue growth of 31% to ₹70.36 crore & net profit growth of 59% to ₹16.25 crore, with EBITDA margin at 28.1%. The company acquired 64.26% of Kronox Lab Sciences & plans ₹50 crore capex over 2-3 years for new products & capacity expansion.
The last 7 quarters
Filings that week
- 12 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 11 Aug 2026Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
- 11 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 10 Aug 2026Announcement under Regulation 30 (LODR)-Press Release / Media Release
- 10 Aug 2026Outcome Of Board Meeting
- 10 Aug 2026Board Meeting Outcome for Outcome Of Board Meeting
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.